Metabolomics data usually undergoes both pre-processing of the raw data and then further pretreatment before any statistical analysis is carried out. Different pre-treatment methods emphasise various aspects of the data, and each method has advantages and disadvantages. The choice of pretreatment method depends on the biological question of interest, characteristics of the data and the chosen data analysis. In this short paper, we investigate the effects of different pre-treatment methods on four metabolomics data sets arising from chemical analysis of propolis samples collected from honey bee colonies in three different locations in Scotland, and also samples from Libya. Propolis has a variety of biological properties including anti-protozoal and anti-inflammatory effects. As a complex mixture, its biological activity depends on its exact composition, which can be investigated via metabolomic analysis. Two techniques of pre-treatment were applied, namely transformation and scaling. The choice of method was found to greatly affect the results of the principal components analysis (PCA) used to explain the variation in the data. The results indicated that there was no notable (if any) improvement to be made by using any transformation techniques. It was also found for all four data sets that Pareto scaling, incorporating mean centring, performed better than the other scaling approaches considered here in terms of PCA, the analysis of interest, because the results explain more of the variation in the data.
sets were used to illustrate the results, namely results of MS analysis of propolis samples collected from honey bee colonies in three different locations in Scotland as well as a further set of samples collected from different locations in Libya. Propolis is a sticky resinous substance produced by honey bees, which consists of a combination of beeswax and resins gathered by the bees from exudates of various surrounding plants. It is used by the bees to seal and maintain their hives, but is also an anti-infective substance which may protect against disease (Saleh et al., 2015; Spivak, 2010, 2012) . Propolis has various important biological properties, including anti-protozoal and anti-inflammatory effects. As a complex mixture, its biological activity depends on its exact composition, which can be examined using metabolomic analysis (Siheri et al., 2016) .
Pre-treatment is an important part of any chemometric data analysis. It involves the application of certain operations to data, to remove noise or unwanted variation or to reduce this to an acceptable level.
Pre-treatment follows pre-processing. Pre-processing is the general term for processes used to convert the raw instrumental data arising from the chemical analysis into clean data, to make it suitable for pre-treatment and further statistical or chemometric analysis which typically use multivariate analyses.
Pre-processing methods include noise filtering, deconvolution, peak detection, alignment and baseline correction, among others (Goodacre et al., 2007) . On the other hand, pre-treatment involves transformation and/or scaling of the pre-processed data to prepare it for data analysis (Brereton, 2009 ).
Metabolomics data are usually presented as a table or array, in which each column represents the chromatographic peak areas or heights (spectral peak intensities) for a putatively identified compound (metabolite) and each row represents a single sample or chemical analysis. Pre-treatment methods include transformation of individual data elements, row scaling operations to make comparable the areas under the spectrum for each sample, and/or column scaling operations on the data for each metabolite. Figure   1 shows sample data used in this paper. Figure 1 : An example of a metabolomics data set from propolis, where column A shows the ID from the MassBank library (Horai et al., 2010) for each spectral peak, column B shows m z total ion chromatogram displayed for the detected peaks, column C shows retention time, column D shows the names of components where available, and columns E, F, G relate to a label for the hive or apiary. These data were transposed before being processed.
The most common pre-treatment operations are logarithmic transformation, mean-centring, and standardisation. Pre-treatment may have positive or negative effects on the outcome of further data analysis. This paper describes the most important and commonly used pre-treatment methods used on metabolomics data, and examines these using several metabolomics data sets described above and in more detail below. Section 2 presents materials and methods, including sample collection, transformation, and scaling, and introduces principal component analysis (PCA), of interest for the analysis of these data. Section 3 presents results, and Section 4 provides discussion and conclusions.
Materials and methods

Sample collection
Data from Scotland
Samples of raw propolis were collected during July and August 2014 by beekeepers from several hives of honey bee colonies in three different areas of Scotland, namely Aberdeenshire in the north-east of Scotland, Dunblane in central Scotland, and Fort William in the north-west of Scotland (see Figure 2 ). These were profiled using liquid chromatography-high-resolution mass spectrometry. The propolis samples contain several hundred compounds, many of which are still unknown structures. The Aberdeenshire data contains twenty seven samples (referred to as data set I). There are fourteen samples from Fort William (data set II) and nine samples from Dunblane (data set III).
Data from Libya
Twelve raw propolis samples were available from different geographical localities in Libya (see map in Qaminis (53km south of Benghazi) (P2); Bayda (east of Benghazi city) (P3); Quba (east of Benghazi city) (P4); Kufra A (south-east Libya) (P5); Kufra B (south-east Libya) (P6); Kufra C (south-east Libya) (P7); Ghadames (south-west Libya) (P8); Tripoli (north-west Libya) (P9); Kasser Khiar (located 80 km east of Tripoli) (P10); Khumas (located 120km east of Tripoli) (P11); and Khumas (120km east of Tripoli) (P12). Samples P1-P12 were all used in this study. 
Transformations
In general, metabolomics data show heteroscedasticity and are often skewed. Also, interactions between the different metabolites are not necessarily additive but can be multiplicative (Boccard et al., 2010) .
The multivariate statistical methods used for the analysis of metabolomics data are more effective when the data are symmetric, and many statistical significance tests assume that the distribution of the data is approximately normal. Therefore, it is useful to convert the data to approximate normality as closely as possible (Brereton, 2009 ). Thus, transformations of the elements of metabolomics data sets are important in helping to achieve this aim. There are two common transformations used in this context, i.e. logarithmic and power transformations.
Logarithmic Transformation
Logarithmic transformation is important as it reduces heteroscedasticity, converts multiplicative models to additive ones, and reduces the influence of large data values such as outliers and occasional high peaks. This is achieved by replacing a data element x ij by its natural log, log(x ij ). Although this has advantages, it has some limitations such as problems handling zeroes or near-zero values, especially when these values are very close to the limit of detection. If data values are below the limit of detection then they are considered as zero, and therefore their logarithms are not defined (Brereton, 2009 ). To overcome this, usually a small value is added to x ij in the event of x ij being zero, before taking the log.
Power Transformation
Power transformation is performed by replacing x ij with x n ij , e.g. for n = 1/2, this is the square root transformation, and so on. This has strengths such as (Brereton, 2009 ):
(a) It reduces the influence of large values such as outliers and occasional high peaks.
(b) It can cope with zero values, removing the need to replace very small values below the limit of detection.
(c) Any uncertainties in small values do not affect data analyses as much as in the case of logarithmic transformation. The smaller a value is relative to other values, the smaller its influence on the n th root transformed data will be.
Drawbacks of this transformation can be summarised as: (c) There are many possible values of the power. Trial and error is needed to identify the most appropriate choice. Especially with multivariate data such as in metabolomics, where each metabolite may have a different distribution, it can be difficult to decide on a suitable power.
Scaling
Before any exploratory analysis of metabolite data, the data must be cleaned, normalised and scaled if there is any removable noise. Two approaches can be applied in data scaling: row scaling (scales each row) and column scaling (scales each column). Column scaling techniques are applied after any preprocessing, transformation and possible data normalisation by row scaling. Many approaches can be used for scaling (row scaling or column scaling). Mean centring and scaling to unit variance (standardisation) are two of the most popular methods. Here we focus on column scaling, assuming that the columns each represent one spectral intensity across all samples (and we did not find row scaling to be necessary).
In mean centring, each column of the data table is scaled to a mean of zero by subtracting the column mean from each value in the column. Mean centring may also be applied before standardisation. In standardisation, each column of the data table is scaled to have unit variance by dividing each value in the column by the standard deviation of the column (Craig et al., 2006) . Scaling affects the results of multivariate analysis, since it determines which correlations are important. This has implications for methods of analysis such as PCA, which examines the covariance or correlation structure of multivariate data. Other scaling methods include range scaling, Pareto scaling and vast scaling. Pareto scaling is very similar to standardisation, but uses the square root of the standard deviation as the scaling factor instead of the standard deviation itself. Vast scaling is an extension of standardisation. The details of all these methods are given below.
1.
Centring Generally, centring pre-treatment allows the researcher to focus on the differences not the similarities in the data. The focus is on isolating and removing systematic variation in the data. However, care is needed when data are heteroscedastic, as the effects of centring may not be sufficient on their own. Usually, centring is applied in combination with other pre-treatment methods. It belongs to the column scaling methods (Goodacre et al., 2007) . Centring converts the metabolite concentrations to fluctuate around zero instead of around the mean concentration for that metabolite (column). Therefore it is used to focus on the fluctuations in the data (Jackson (1991) and Bro and Smilde (2003) ), leaving only the relevant variation (between the samples) for analysis. Centring can be applied on its own or as part of any of the methods described below.
Scaling based on Data Dispersion
Several scaling techniques were tested that use a dispersion measure as a scaling factor. These also belong to the column-scaling techniques, as the scaling is applied to each column of the data set (van den Berg et al., 2006) . We consider standardisation (Jackson, 1991) , Pareto scaling (Eriksson et al., 1999) , range scaling (Smilde et al., 2005) , and vast scaling (Keun et al., 2003) .
In these methods, the mean and standard deviation are defined as:
where i and j index the data rows and columns respectively, and N is the number of rows.
Standardisation
This is a form of scaling performed by mean centring each metabolite value using the respective mean of all sample values for that metabolite, and then dividing by the standard deviation of all the sample values for that metabolite. The formula is given bỹ
Standardisation is also called auto-scaling or unit variance scaling, as, after standardisation, all metabolites have a standard deviation of one and have comparable scales. The main advantage is that all metabolites become equally important, but this approach can increase the influence of measurement errors (van den Berg et al., 2006). After standardisation, the data becomes dimensionless.
Range Scaling
The scaling factor in the range scaling method is the range within each metabolite. In this case,
referring to metabolite j. Range scaling allows comparison of metabolites with respect to their biological response range. In this approach, all metabolites are equally important, and their scaling is related to the biology. However, increased measurement errors and sensitivity to outliers may be noticed when using this scaling method (van den Berg et al., 2006) . As in the case of standardisation, the data becomes dimensionless.
Pareto Scaling
Here the square root of the standard deviation is used as the scaling factor. It aims to reduce the influence of large values without losing important information concerning the structure of the data.
The formula is:
Pareto scaled data is closer to the original data than standardised data, but this depends very much on the large values in the data set.
Vast Scaling
This is an extension of standardisation. It aims to give more importance to those metabolites that appear to have small variances. To achieve that, the method uses the coefficient of variation statistic as a scaling factor. The formula is given by:
wherex j sj is the inverse of the coefficient of variation of the jth metabolite (column j). This method is not useful when large induced variation exists, and there is no group structure in the data.
All of these scaling methods belong to the column scaling methods, as the scaling is applied to the columns (metabolites) in the data set.
Scaling based on Data Level
Level Scaling
Scaling based on average values uses a size measure instead of a measure of spread as the scaling factor. Level scaling is one such method. It converts metabolite concentrations into changes relative to the size of the average concentration of the metabolite, by using the mean concentration as the scaling factor. The formula for level scaling of metabolite j is given by:
This method is suitable for the identification of biomarkers. It is however prone to increase measurement errors (van den Berg et al., 2006). Level scaling, like the scaling methods based on data dispersion, also belongs to the column scaling methods.
Principal component analysis (PCA)
Metabolomics data records information on many compounds. To account for all of these manageably in analysis, we must reduce the multidimensional information to a lower-dimensional space. Typically two or three dimensions are used for visualisation of data. One way to achieve dimension reduction is by using principal component analysis (PCA; Jackson, 1991) . PCA is applied commonly in widely differing areas from neuroscience to computer graphics, because it is relatively simple and effective.
PCA is one of several multivariate statistics techniques that can be used to visualise clusters and The number of principal components is determined by the rank of the data matrix, which is less than or equal to the smaller of the number of rows and columns in the data. In the metabolomics context this is likely to be less than or equal to the number of samples in the original data. In this study, the number of PCs is equal to the number of samples.
PCA is sensitive to the scaling of the original variables, so is commonly used on the correlation matrix of the variables or the covariance matrix of scaled variables rather than the covariances of the original data. This overcomes the effect of possibly widely differing variances in the original variables, even when those variables may be measured on the same scale. Not doing so leads to more dispersed variables dominating the analysis.
Each PC is characterised by two sets of information, the scores and the loadings. Scores plots often
give useful information about the relationships between the samples (rows in the data). These plots can be produced as the projections of the samples to a single eigenvector (PC) versus sample number or onto the plane formed by the first two eigenvectors (first two PCs). A projection of the samples to the two eigenvectors associated with the largest eigenvalues shows the greatest amount of information about the relationship between the samples that can be shown in two (linear) dimensions. The original space here consists of metabolite expression profiles. Scatter plots of the first two or three PCs will reflect most of the information in the original data set of higher dimension, and are a useful way to see any clusters of groups of similar observations in the data.
The eigenvectors are found from an eigenanalysis of the covariance matrix or the correlation matrix of the data matrix X or a singular value decomposition of X itself. PCA decomposes the variation of data matrix X into scores T , loadings P , and a residuals matrix E, where P is a I × A matrix containing the A selected loadings and T is a J × A matrix containing the accompanying scores.
where 
Results
All calculations were performed using the R software (R Core Team, 2019). One data matrix X was input to the R software for each set of propolis samples, after pre-processing of the data. Here matrix X is MS data in which row labels are sample identifiers and columns are variables. After pre-processing, we apply scaling techniques on the different data sets contained in each matrix X. Our goal is to carry out PCA on these data, therefore the optimal scaling technique is considered as the one for which the maximum variance is explained by the first few orthogonal principal components. Therefore, PCA is performed to evaluate this, as an objective numerical measure to evaluate the methods, and PC scores plots and loadings plots are also presented, to compare any patterns of clustering arising after the different scaling methods are used.
Application of pre-treatment
As described, pre-treatment takes place in the second stage of data processing, after pre-processing, to remove or reduce any uninduced variation (from sampling, sample work-up and analytical measurement errors) as much as possible, and, if it exists, heteroscedasticity of the data. The usual order of applying pre-treatment methods to a data set is to first transform the individual elements of the data set, then to apply row scaling (if used), and finally to scale the columns, as was done here. Scaling methods (row or column) have been classified as centring, scaling based on data dispersion and scaling based on average values. The two most common methods of transforming the elements of a data matrix are the log and the power transformations, and several commonly used scaling approaches have been described.
No element transformation was chosen in this case. Using a power transformation had very little effect. Although using a log transformation brought the data much closer to normality, it also led to much less interpretable results from PCA, for each of the data sets I, II, III and Libya. Row scaling was also found to be unnecessary (results not shown). 6 (right plots) , the loadings on PC1 and PC2 for standardisation, range, vast and level scaling have a similar shape. For the other two scaling methods, the mean-centred true (raw) data and Pareto, the plots of the loadings on both PCs have similar shapes. In general, the shapes of loadings for the mean-centred true and Pareto approaches have the highest similarity among all the plotted loadings, and the other approaches give different results from these but similar results to each other. Similar conclusions can be drawn from Figure 7 for the Libyan data. These conclusions also apply to the scores plots, where the results for the mean-centred true (raw) data and Pareto are similar but different from the other results.
In summary, the application of different pre-treatment methods had a large effect on the resulting data used as input for data analysis, as shown by the varying effects seen in Figures 4 to 7 . For instance, standardisation, range, vast and level scaling showed very many large peaks in the loadings, while after Pareto scaling (or mean centring alone) relatively fewer large peaks were present, thus giving more interpretable results indicating more important metabolites. While the results for the mean-centred true data and Pareto-scaled data are similar, Pareto scaling identifies more peaks than mean centring alone, while still being interpretable. It is clear that different results will be obtained when the differently pre-treated data sets are used as input for data analysis. From these tables, it can be observed that Pareto scaling performed much better than the other scaling methods in terms of PCA, because it explains more of the variation in the data sets in every case. The first two PCs explain 79.00%, 74.78%, 76.91% and 71.79% of the total variation of data sets I, II, III and Libya respectively.
We conclude that Pareto scaling (incorporating mean centring) is the most useful type of scaling for each of these samples. We see clearly from Tables 1 to 4 that the Pareto option leads to much the most variation in data sets I, II, III and Libya being explained by the first two PCs, and therefore gives the most informative lower-dimensional analysis of the data. 
SUMMARY AND CONCLUSIONS
In this article we have given a short review of pre-treatment methods used in processing metabolomics data, including transformation and scaling methods. There are two approaches that can be applied for data scaling: row scaling, and column scaling, with different scaling methods available for either. Scaling methods can be classified as centring, scaling based on data dispersion and scaling based on average values. The advantages and disadvantages of applying these pre-treatment methods were discussed.
Column scaling makes the columns more comparable to each other for subsequent analysis, and makes sense in the context of metabolomics data where the columns represent different metabolites detected in the samples analysed.
We considered mean centring alone, and standardisation, range scaling, Pareto scaling, vast scaling and level scaling, each including mean centring. We applied these six different column scaling methods to four different metabolomics data sets arising from MS analysis of samples of honey bee propolis from different locations in Scotland and Libya, to compare the effects of these on the results of principal component analysis (PCA) of the treated data. We examined PC scores plots and loadings plots, for graphical representations of the data in terms of the first two PCs, as well as the percentage of variance explained by the first two principal components.
We conclude from the results that it is best for these data sets to be mean-centred and Pareto-scaled prior to using PCA, where these operations are carried out on the columns of the data (metabolites).
This approach led to much the highest percentage of variance being explained by the PCA, relative to other scaling approaches, for every data set. We did not find it necessary to first scale the rows of the data to a constant total, nor to carry out data transformation first, as this had little effect on the data used here.
These conclusions are likely to be true of other similar data sets as well, so we recommend these choices for analysis of such MS-based metabolomics data, notably mean centring and Pareto scaling of the data columns. Mortazavi-Tabatabaei et al. (2013) , in a less extensive study, concluded, using NMR metabolomics data from human blood samples, that mean centring separated two different patient groups more clearly than auto-scaling, but did not examine Pareto scaling. The authors in van den Berg et al. (2006) studied the effects of several pre-treatment methods and concluded that the pre-treatment approach crucially affected the outcome of the data analysis, for functional genomics data. Therefore, what is the best approach may depend on the context, as also concluded by Craig et al. (2006) . It would be interesting to carry out similar analyses on a wider variety of such data sets.
